Abstract
Toxicokinetic characteristics of naringin and its metabolite naringenin were investigated in beagle dogs after oral administration of naringin at the doses of 20, 100, or 500 mg/kg/day in a repeated-dose study for 1, 30, 90, and 180 days. Plasma concentrations of naringin and naringenin were determined by a rapid resolution liquid chromatography/electrospray ionization/tandem mass spectrometric method. The results showed that no differences in systemic exposure were observed between male and female beagle dogs. Systematic exposure exhibited dose-dependent increase for both naringin and naringenin. No significant accumulations were observed. Results would be taken into consideration for the interpretation of toxicology findings and provide a reference for clinical safety assessment.
Acknowledgments
This work was jointly supported by the National Key Technology R&D Program (No. 2006BAI06A02-2), the Guangdong-Hongkong Major Breakthrough Project of Key Realms (No. 2009A030901009), and the National Major Scientific and Technical Special Project (No. 2011ZX09102-011-03).
Notes
1. These authors contributed equally to this work.